Sarah Cavanaugh, SVP OF Corporate AFFAIRS & Administration at Celldex Therapeutics, Inc. (CLDX), sold 63,979 shares at $36.73 ($2.3M) on 2022-08-17, disclosed to the SEC on 2022-08-19.
Open-market sale of $2.3M CLDX by SVP OF Corporate AFFAIRS & Administration. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.73 | 31,312 | $1.2M | 49.0% |
| 2 | $36.73 | 31,312 | $1.2M | 49.0% |
| 3 | $36.38 | 1,355 | $49K | 2.1% |
| Total | $36.72 avg | 63,979 | $2.3M | 100% |
| Filing → |
| CLDX | SELL | 2021-11-03 | $595K | — | Filing → |
| CLDX | BUY | 2020-06-11 | $5K | — | Filing → |